Clear Filters

Resource Type
  • DeviceEquipmentTechnology (3)
  • Dataset (1)
Usage / Applications
  • cell separation (1)
Contributor Organization
  • University of Pennsylvania (3)
  • Ben May Department for Cancer Research (1)
  • Boston University (1)
Search Results for: Ben Stanger returned 4 results
CaTCh FISH Chip (Circulating Tumor Cell Fluorescence in situ Hybridization Chip)
RRID:SCR_015810
The CaTCh FISH Chip is a magnetic micropore chip for rapid (<1 hour) unbiased circulating cell isolation and in situ RNA analysis. The chip was able to isolate rare circulating tumor cells from whole blood of a pancreatic cancer mouse model and from patients with advanced pancreatic cancer. The chip works by first removing white blood cells using an innovative high throughput magnetic micropore filter, then removing red blood cells and platelets using size exclusion. The remaining cell population is enriched for circulating tumor cells and can be immediately RNA-profiled using fluorescent in situ hybrization (FISH) against selected markers. As a cell sorting tool, CaTCh FISH achieved LOD ~1 cell per mL blood compared to conventional cytometry with LOD of ~100 cell per mL whole blood, and can handle large volumes (>10 mL). Captured cells can be directly imaged on the chip with a 100� objective. Though originally described as a diagnostic device for circulating tumor cells, the chip can be adapted for other cell types.
Type 1 calreticulin mutations activate the IRE1α-XBP1 pathway of the unfolded protein response to drive MPN
GSE173805
Biomimetic pancreatic cancer on-chip in vitro platform

An organotypic PDAC-on-a-chip culture model that emulates vascular invasion and tumor–blood vessel interactions to better understand pancreatic ductal adenocarcinoma (PDAC)-vascular interactions. The model features a 3D matrix containing juxtaposed PDAC and perfusable endothelial lumens.
iPreP platform for long-term ex vivo preservation of human islets

A nanofibrillar cellulose hydrogel-based islet-preserving platform (iPreP) that can preserve islet viability, morphology, and function for nearly 12 weeks ex vivo, and with the ability to ameliorate glucose levels upon transplantation into diabetic hosts. Our platform has potential applications in the prolonged maintenance of human islets, providing an expanded time window for pretransplantation assessment and islet studies.
.